Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neuropathy clinical trials
Every US clinical trial registered for Neuropathy — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
23 US clinical trials · 11 currently recruiting
The research picture
Neuropathy has 23 registered US clinical trials, 11 of them open to new participants right now — about 48% of the total.
- 11
- recruiting participants now
- 48%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 3
- top sponsor: Dana-Farber Cancer Institute
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care
University of Texas Southwestern Medical Center
NCT02804438
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
National Cancer Institute (NCI)
NCT02610439
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
University of Louisville
NCT04208828
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Jaeb Center for Health Research
NCT06837181
Data Collection of Standard Care of Patients in the EMG Section
National Institute of Neurological Disorders and Stroke (NINDS)
NCT05041387
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
Brigham and Women's Hospital
NCT01788410
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
NCT07390617
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
Erchonia Corporation
NCT06912646
Diabetic Neuropathy in Spinal Cord Stimulator Patients
University of Chicago
NCT04687215
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Dana-Farber Cancer Institute
NCT06807294
Daily Hand-Held Vibration Therapy
Indiana University
NCT04207437
Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials
M.D. Anderson Cancer Center
NCT04650178
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT04917796
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT05121558
BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma
Bexion Pharmaceuticals
NCT05322590
Improving Autonomic Function and Balance in Diabetic Neuropathy
VA Office of Research and Development
NCT01864460
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
M.D. Anderson Cancer Center
NCT03219502
Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy
NeuFit - Neurological Fitness and Education
NCT05442021
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
BioDelivery Sciences International
NCT02643251
Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy
Columbia University
NCT01163682
Tango for Neuropathy Among Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
NCT05114005
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
St. Jude Children's Research Hospital
NCT01506453
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)
University of Arizona
NCT03365895
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Neuropathy Trial Landscape
ClinicalTrials.gov lists 23 US studies indexed under Neuropathy, and 11 of those are currently open to recruitment — roughly 48% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Neuropathy shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Neuropathy is led by Dana-Farber Cancer Institute with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 23 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Neuropathy?
PlainTrial tracks 23 US clinical trials for Neuropathy, of which 11 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Neuropathy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.